Compare alternative providers
Alternatives to Andrew Meds
Andrew Meds grades C (67.1/100), #188 of 542 on our scorecard. Start with a featured alternative, then explore providers with similar listed prices and treatment options. Compare their scores and terms below.
You're comparing against
Andrew Meds →Featured alternative
CoreAge Rx scores 89.5/100. Check the price conditions and care terms against Andrew Meds.
CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
More options to compare
An established pharmacy operator with steady mid-market pricing and a broad catalog.
A both-molecule compounded program that publishes its prices up front — semaglutide $199/mo, tirzepatide $299/mo — across a 50-state clinician network, with an optional coaching-plus-labs membership and a NAD+/microdosing menu on the side.
One of the few programs whose headline is the actual monthly rate, with the prescribing physician and the dispensing pharmacy both named.
A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.
Mass-market app-first program with nationwide reach and consumer-grade polish.
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
The 6 alternatives above offer other options to compare with Andrew Meds. Every provider we grade — all 542 of them — is scored on the same six factors: browse every graded provider.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.